A Selective Nuclear Factor-κB Inhibitor, JSH-23, Exhibits Antidepressant-like Effects and Reduces Brain Inflammation in Rats
Altogether, these data suggest that NF-κB may be a potential therapeutic target for pharmacological interventions for depression.
Authors
- Abed N. Azab
- J. Kaplanski
- Ahmad Nassar
Institutions
- Ben-Gurion University of the Negev (IL)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-09-26
- DOI
- https://doi.org/10.3390/ph17101271
- Citations
- 2
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.31